Emilio Bria

Studi sui taxani, studio sul trastuzumab

Emilio Bria, B. Vanni, Federica Cuppone, 2004 .

Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment.

Emilio Bria, G. Viale, I. Sperduti, 2016, Breast.

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

Emilio Bria, Antonello Vidiri, Stefano Telera, 2011, Journal of experimental & clinical cancer research : CR.

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer

Laura Ferrari, Daniele Rossini, Emilio Bria, 2015, British Journal of Cancer.

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

Matteo Brunelli, Emilio Bria, Federica Cuppone, 2015, PloS one.

MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy.

Emilio Bria, Aldo Scarpa, A. Scarpa, 2017, Annals of translational medicine.